References
van den Heuvel JM, Hovels AM, Buller HR, Mantel-Teeuwisse AK, de Boer A, Maitland-van der Zee AH (2018) NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The Netherlands. Thromb J 16:7. https://doi.org/10.1186/s12959-017-0156-y
Maura G, Billionnet C, Drouin J, Weill A, Neumann A, Pariente A (2019) Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011–2016. BMJ Open 9(4):e026645. https://doi.org/10.1136/bmjopen-2018-026645
Haas S, Ageno W, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Dalsgaard Nielsen J, Kayani G, Zaghdoun A, Farjat AE, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK (2019) Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD-VTE patients. J Thromb Haemost. https://doi.org/10.1111/jth.14548
Zhu J, Alexander GC, Nazarian S, Segal JB, Wu AW (2018) Trends and variation in oral anticoagulant choice in patients with atrial fibrillation, 2010–2017. Pharmacotherapy 38(9):907–920. https://doi.org/10.1002/phar.2158
Raschi E, Bianchin M, Fantoni C, Ageno W, De Ponti F, De Ponti R (2017) Evolving cardiovascular uses of direct-acting oral anticoagulants: a paradigm shift on the horizon? Intern Emerg Med 12(7):923–934. https://doi.org/10.1007/s11739-017-1724-7
Barnes GD, Kline-Rogers E (2015) Engaging with quality improvement in anticoagulation management. J Thromb Thrombolysis 39(3):403–409. https://doi.org/10.1007/s11239-015-1184-8
Testa S, Paoletti O, Zimmermann A, Bassi L, Zambelli S, Cancellieri E (2012) The role of anticoagulation clinics in the era of new oral anticoagulants. Thrombosis 2012:835356. https://doi.org/10.1155/2012/835356
Barnes GD, Nallamothu BK, Sales AE, Froehlich JB (2016) Reimagining anticoagulation clinics in the era of direct oral anticoagulants. Circ Cardiovasc Qual Outcomes 9(2):182–185. https://doi.org/10.1161/CIRCOUTCOMES.115.002366
Tosetto A, Testa S, Palareti G, Paoletti O, Nichele I, Catalano F, Morandini R, Di Paolo M, Tala M, Esteban P, Cora F, Mannino S, Maroni A, Sessa M, Castaman G (2019) The effect of management models on thromboembolic and bleeding rates in anticoagulated patients: an ecological study. Intern Emerg Med. https://doi.org/10.1007/s11739-019-02148-7
Testa S, Alatri A, Paoletti O, Morstabilini G, Medagliani MA, Denti N, Martellenghi E (2006) Reorganisation of an anticoagulation clinic using a telemedicine system: description of the model and preliminary results. Intern Emerg Med 1(1):24–29
Cios DA, Baker WL, Sander SD, Phung OJ, Coleman CI (2009) Evaluating the impact of study-level factors on warfarin control in US-based primary studies: a meta-analysis. Am J Health Syst Pharm 66(10):916–925. https://doi.org/10.2146/ajhp080507
Palareti G, Antonucci E, Migliaccio L, Erba N, Marongiu F, Pengo V, Poli D, Testa S, Tosetto A, Tripodi A, Moia M, centers participating in the F-S-R, (2017) Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago. Intern Emerg Med 12(8):1109–1119. https://doi.org/10.1007/s11739-017-1678-9
ISTAT_(Italian_Statistical_Bureau) (2019) Aspetti della vita quotidiana—Anno 2018. https://www.istat.it/it/archivio/91926. Rome
Barco S, Granziera S, Coppens M, Douxfils J, Nijkeuter M, Riva N, Vanassche T, Zhang G, Lin M, Kamphuisen PW, Cohen AT, Beyer-Westendorf J (2019) Determinants of the quality of warfarin control after venous thromboembolism and validation of the SAMe-TT2-R2 score: an analysis of Hokusai-VTE. Thromb Haemost 119(4):675–684. https://doi.org/10.1055/s-0039-1678546
van Es N, Coppens M, Schulman S, Middeldorp S, Buller HR (2014) Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood 124(12):1968–1975. https://doi.org/10.1182/blood-2014-04-571232
Ageno W, Mantovani LG, Haas S, Kreutz R, Monje D, Schneider J, van Eickels M, Gebel M, Zell E, Turpie AG (2016) Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study. Lancet Haematol 3(1):e12–21. https://doi.org/10.1016/S2352-3026(15)00257-4
Ntaios G, Papavasileiou V, Makaritsis K, Vemmos K, Michel P, Lip GYH (2017) Real-world setting comparison of nonvitamin-K antagonist oral anticoagulants versus vitamin-K antagonists for stroke prevention in atrial fibrillation: a systematic review and meta-analysis. Stroke 48(9):2494–2503. https://doi.org/10.1161/STROKEAHA.117.017549
Burn J, Pirmohamed M (2018) Direct oral anticoagulants versus warfarin: is new always better than the old? Open Heart 5(1):e000712. https://doi.org/10.1136/openhrt-2017-000712
Pisters R, Elvan A, Crijns H, Hemels MEW (2018) Optimal long-term antithrombotic management of atrial fibrillation: life cycle management. Neth Heart J 26(6):311–320. https://doi.org/10.1007/s12471-018-1118-0
Barco S, Schmidtmann I, Ageno W, Bauersachs RM, Becattini C, Bernardi E, Beyer-Westendorf J, Bonacchini L, Brachmann J, Christ M, Czihal M, Duerschmied D, Empen K, Espinola-Klein C, Ficker JH, Fonseca C, Genth-Zotz S, Jimenez D, Harjola VP, Held M, Iogna Prat L, Lange TJ, Manolis A, Meyer A, Mustonen P, Rauch-Kroehnert U, Ruiz-Artacho P, Schellong S, Schwaiblmair M, Stahrenberg R, Westerweel PE, Wild PS, Konstantinides SV, Lankeit M, Ho TPEI (2019) Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial. Eur Heart J. https://doi.org/10.1093/eurheartj/ehz367
Vinson DR, Mark DG, Chettipally UK, Huang J, Rauchwerger AS, Reed ME, Lin JS, Kene MV, Wang DH, Sax DR, Pleshakov TS, McLachlan ID, Yamin CK, Elms AR, Iskin HR, Vemula R, Yealy DM, Ballard DW, e SIotKPCN (2018) Increasing safe outpatient management of emergency department patients with pulmonary embolism: a controlled pragmatic trial. Ann Intern Med. https://doi.org/10.7326/M18-1206
Belfiore A, Palmieri VO, Di Gennaro C, Settimo E, De Sario MG, Lattanzio S, Fanelli M, Portincasa P (2019) Long-term management of chronic heart failure patients in internal medicine. Intern Emerg Med. https://doi.org/10.1007/s11739-019-02024-4
Aaronson EL, Kim J, Hard GA, Yun BJ, Kaafarani HMA, Rao SK, Weilburg JB, Lee J (2019) Emergency department visits by patients with an internal medicine specialist: understanding the role of specialists in reducing ED crowding. Intern Emerg Med 14 (5):777–782. https://doi.org/10.1007/s11739-019-02051-1.
Solvik UO, Lokkebo E, Kristoffersen AH, Brodin E, Averina M, Sandberg S (2019) Quality of warfarin therapy and quality of life are improved by self-management for 2 years. Thromb Haemost. https://doi.org/10.1055/s-0039-1693703
Kulkarni R (2018) Use of telehealth in the delivery of comprehensive care for patients with haemophilia and other inherited bleeding disorders. Haemophilia 24(1):33–42. https://doi.org/10.1111/hae.13364
Heiss C, Madaric J, Belch J, Brodmann M, Mazzolai L (2019) The compelling arguments for the need of medical vascular physicians in Europe. Vasa. https://doi.org/10.1024/0301-1526/a000810
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None reported.
Statements of human and animal rights
This article does not contain data derived by any current studies with human participants performed by any of the authors.
Informed consent
For this type of study, formal informed consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The work of Luca Valerio, Alice Trinchero, and Stefano Barco is supported by the German Federal Ministry of Education and Research (BMBF 01EO1003 and 01EO1503).
Rights and permissions
About this article
Cite this article
Valerio, L., Trinchero, A. & Barco, S. Telemedicine and decentralized models of care: from anticoagulant monitoring to an expanded concept of vascular medicine. Intern Emerg Med 14, 1213–1215 (2019). https://doi.org/10.1007/s11739-019-02174-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-019-02174-5